Microscopic scleral invasion in retinoblastoma: Clinicopathological features and outcome

Archives of Ophthalmology

Volumn 127, Issue 8, 2009, Pages 1006-1010

  Cuenca, Adriana ^a   Giron, Flor ^b   Castro, Daisy ^b   Fandiño, Adriana ^c   Guitter, Myriam ^c   De Dávila, María T G ^c   Chantada, Guillermo ^c  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b NATIONAL AUTONOMOUS UNIVERSITY OF HONDURAS   (Honduras)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; MESNA; METHOTREXATE; VINCRISTINE SULFATE;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; ENUCLEATION; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; OPTIC NERVE; ORBIT; ORBIT METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RELAPSE; RETINOBLASTOMA; RISK FACTOR; SCLERA DISEASE;

CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; EYE ENUCLEATION; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RETINAL NEOPLASMS; RETINOBLASTOMA; SCLERAL DISEASES; SURVIVAL RATE;

EID: 68549101956     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.174     Document Type: Article

References (21)

1. Abramson DH. Retinoblastoma incidence in the United States. Arch Ophthalmol. 1990;108(11):1514.
2. Abramson DH, Schefler AC. Update on retinoblastoma. Retina. 2004;24(6):828-848.
3. Rodriguez-Galindo C, Wilson MW, Chantada G, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122(3):e763-e770. http:pediatrics.aappublications.org/cgi/content/full/122/3/e763.
4. Chantada GL, Dunkel IJ, de Davila MT, Abramson DH. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol. 2004;88(8):1069-1073.
5. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer. 1996;77(6):1206-1213.
6. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96(2):217-222.
7. Messmer EP, Heinrich T, Hopping W, de Sutter E, Havers W, Sauerwein W. Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 1991;98(2):136-141.
8. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77(9):544-548.
9. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120(7):923-931.
10. Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol. 2001;119(1):41-48.
11. Chantada GL, Dunkel IJ, Antoneli CB, et al. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Pediatr Blood Cancer. 2007;49(3):256-260.
12. Stannard C, Lipper S, Sealy R, Sevel D. Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases. Br J Ophthalmol. 1979;63(8):560-570.
13. Chantada GL, Casco F, Fandino AC, et al. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion. Ophthalmology. 2007;114(11):2083-2089.
14. Schvartzman E, Chantada G, Fandino A, de Dávila MT, Raslawski E, Manzitti J. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol. 1996;14(5):1532-1536.
15. Chantada G, Fandino A, Davila MT, et al. Results of a prospective study for the treatment of retinoblastoma. Cancer. 2004;100(4):834-842.
16. Chantada GL, Fandino AC, Raslawski EC, et al. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer. 2005;44(5):455-460.
17. Antoneli CB, Ribeiro KB, Rodriguez-Galindo C, et al. The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement. J Pediatr Hematol Oncol. 2007;29(10):700-704.
18. Honavar S. Orbital retinoblastoma. In: Singh A, ed. Clinical Ophthalmic Oncology. Philadelphia, PA: Saunders Elsevier; 2007:477-483.
19. Chantada GL, Guitter MR, Fandino AC, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatr Blood Cancer. 2009;52(2):218-222.
20. Kim JW, Kathpalia V, Dunkel I, Wong RK, Riedel E, Abramson DH. Orbital recurrence of retinoblastoma following enucleation. Br J Ophthalmol. 2009;93(4):463-467.
21. MacKay CJ, Abramson DH, Ellsworth RM. Metastatic patterns of retinoblastoma. Arch Ophthalmol. 1984;102(3):391-396.